[Therapeutic possibilities in HIV infection and AIDS].
Improvement regarding the diagnostics and therapy of secondary manifestations in HIV infection has had a positive influence on the quality of life as well as life-expectancy of AIDS patients. Early treatment with high doses, critical evaluation, and prophylactic therapy are of outstanding importance. Since recently, effective modes of antiretroviral therapy have been available. A number of cutaneous manifestations are valuable markers of incipient immunodeterioration, and thus can serve as indicative criteria regarding antiretroviral therapy. Whereas current possibilities of immunorestoration have been unsatisfactory as far, we expect more of the development of defined lymphokines and growth factors with defined and controllable effects.
Rasokat
H
H
Universitäts-Hautklinik Köln.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009894:Opportunistic Infections / Q000150:complications / Q000628:therapy*; D012514:Sarcoma, Kaposi / Q000628:therapy*; D012871:Skin Diseases / Q000150:complications; D012874:Skin Diseases, Infectious / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine
Therapeutische Möglichkeiten bei HIV-Infektion und AIDS.